ARDS

Featured Neuroscience Open Neuroscience Articles

·April 29, 2020

COVID-19 study shows that men have over double the death rate of women

Males who contract COVID-19 have 2.5 times the death rate of women. Being males is a significant risk factor for worse disease severity, regardless of age. Researchers found a similar trend in data from the 2003 SARS outbreak. The study speculates the reason why males are more prone to negative outcomes of coronavirus is due to levels of ACE2, which is significantly higher in males than females. Read More

Featured Neurology Neuroscience Open Neuroscience Articles

·April 24, 2020

Highlighting diabetes risks in COVID-19

The risk of severe complications, including death, from coronavirus, is almost 50% higher in those with diabetes than the general population. Although it is yet to be verified in humans, new findings suggest diabetes may not only be a risk factor for severe COVID-19, but the infection could result in causing new onset of diabetes due to the damage it causes to pancreatic beta cells. Read More

Featured Genetics Neuroscience

·April 24, 2020

Asthma drug in clinical trial to treat severe COVID-19 patients

A new clinical trial is underway to test ibudilast, an asthma drug approved in Japan, for the treatment of severe COVID-19. Ibudilast is a MIF inhibitor. MIF is a gene that regulates immune response and is a driver of inflammation which results in the cytokine storm associated with coronavirus. Read More

Featured Neurology Neuroscience Neuroscience Videos Open Neuroscience Articles

·April 16, 2020

Researchers investigate overactive immune cells as cause of COVID-19 deaths

Study investigates whether overactive immune cells that produce neutrophil extracellular traps (NETs) are responsible for more severe and lethal cases of coronavirus. Read More

Featured Neuroscience Open Neuroscience Articles

·April 15, 2020

COVID-19: Exercise may protect against deadly complication

Regular exercise may help prevent or reduce the severity of ARDS for those with coronavirus. A single session of exercise increases the production of a critical antioxidant, called EcSOD, helping to reduce the effects of COVID-19 infection. Read More

Featured Neuroscience

·April 6, 2020

Anti-clotting drug could reduce ARDS deaths as a result of COVID-19

A new clinical trial is being established to see if anti-clotting drugs, commonly used for heart attack and stroke patients, can help treat COVID-19 patients who develop ARDS. If successful, the tPA drugs could help alleviate the expected ventilator shortage problem we are likely to experience soon. Read More

Featured Neuroscience Open Neuroscience Articles

·April 4, 2020

Study identifies characteristics of patients with fatal COVID-19

Based on data from COVID-19 patients from Wuhan, China, that died as a result of the infection, researchers have identified many symptom commonalities the patients shared. Read More